CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 300.00
+4.00 (1.35%)
Jun 24, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 5.87 billion as of June 23, 2026. Its market cap has decreased by -56.78% in one year.
Market Cap
5.87B
Enterprise Value
1.09B
Revenue
3.67B
Ranking
n/a
PE Ratio
83.83
Stock Price
300.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 5.87B, a decrease of -56.41%. That is a compound annual growth rate of -11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 5.87B | -25.72% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 7.37B |
| OncoTherapy Science | 7.29B |
| StemCell Institute | 7.17B |
| ADR120S | 7.01B |
| MEDINET | 6.97B |
| Kidswell Bio | 6.80B |
| Soiken Holdings | 6.43B |
| Carna Biosciences | 6.35B |